115 related articles for article (PubMed ID: 20394492)
1. A 10-year open follow-up of eczema and respiratory symptoms in patients with atopic dermatitis treated with topical tacrolimus for the first 4 years.
Mandelin JM; Remitz A; Virtanen HM; Malmberg LP; Haahtela T; Reitamo S
J Dermatolog Treat; 2010 May; 21(3):167-70. PubMed ID: 20394492
[TBL] [Abstract][Full Text] [Related]
2. Respiratory symptoms, bronchial hyper-responsiveness, and eosinophilic airway inflammation in patients with moderate-to-severe atopic dermatitis.
Kyllönen H; Malmberg P; Remitz A; Rytilä P; Metso T; Helenius I; Haahtela T; Reitamo S
Clin Exp Allergy; 2006 Feb; 36(2):192-7. PubMed ID: 16433856
[TBL] [Abstract][Full Text] [Related]
3. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients.
Reitamo S; Rustin M; Harper J; Kalimo K; Rubins A; Cambazard F; Brenninkmeijer EE; Smith C; Berth-Jones J; Ruzicka T; Sharpe G; Taieb A;
Br J Dermatol; 2008 Sep; 159(4):942-51. PubMed ID: 18637898
[TBL] [Abstract][Full Text] [Related]
4. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
[TBL] [Abstract][Full Text] [Related]
5. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
[TBL] [Abstract][Full Text] [Related]
6. Eczema molluscatum in tacrolimus treated atopic dermatitis.
Wetzel S; Wollenberg A
Eur J Dermatol; 2004; 14(1):73-4. PubMed ID: 14965804
[TBL] [Abstract][Full Text] [Related]
7. Topical tacrolimus in the treatment of atopic dermatitis--does it benefit the airways? A 4-year open follow-up.
Virtanen H; Remitz A; Malmberg P; Rytilä P; Metso T; Haahtela T; Reitamo S
J Allergy Clin Immunol; 2007 Dec; 120(6):1464-6. PubMed ID: 17910892
[No Abstract] [Full Text] [Related]
8. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
[TBL] [Abstract][Full Text] [Related]
9. Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients.
Mastrandrea F; Serio G; Minelli M; Minardi A; Scarcia G; Coradduzza G; Parmiani S
Allergol Immunopathol (Madr); 2000; 28(2):54-62. PubMed ID: 10804094
[TBL] [Abstract][Full Text] [Related]
10. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
11. Hand eczema and long-term prognosis in atopic dermatitis.
Rystedt I
Acta Derm Venereol Suppl (Stockh); 1985; 117():1-59. PubMed ID: 2931938
[TBL] [Abstract][Full Text] [Related]
12. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
[TBL] [Abstract][Full Text] [Related]
14. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper.
Krejci-Manwaring J; McCarty MA; Camacho F; Manuel J; Hartle J; Fleischer A; Feldman SR
J Drugs Dermatol; 2008 Jul; 7(7):643-6. PubMed ID: 18664156
[TBL] [Abstract][Full Text] [Related]
15. Effective therapy of childhood atopic dermatitis allays food allergy concerns.
Thompson MM; Hanifin JM
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S214-9. PubMed ID: 16021177
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis.
Hanifin JM; Paller AS; Eichenfield L; Clark RA; Korman N; Weinstein G; Caro I; Jaracz E; Rico MJ;
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S186-94. PubMed ID: 16021174
[TBL] [Abstract][Full Text] [Related]
17. Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream.
Abramovits W; Fleischer AB; Jaracz E; Breneman D
J Drugs Dermatol; 2008 Dec; 7(12):1153-8. PubMed ID: 19137769
[TBL] [Abstract][Full Text] [Related]
18. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
Hui RL; Lide W; Chan J; Schottinger J; Yoshinaga M; Millares M
Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860
[TBL] [Abstract][Full Text] [Related]
19. Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus.
Naylor M; Elmets C; Jaracz E; Rico JM
J Dermatolog Treat; 2005 Aug; 16(3):149-53. PubMed ID: 16096180
[TBL] [Abstract][Full Text] [Related]
20. Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study.
Papp KA; Werfel T; Fölster-Holst R; Ortonne JP; Potter PC; de Prost Y; Davidson MJ; Barbier N; Goertz HP; Paul C
J Am Acad Dermatol; 2005 Feb; 52(2):240-6. PubMed ID: 15692468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
